Drug

Efsubaglutide alfa clinical trials

Also written Supaglutide.

studies test it: 12
open now: 5
in phase 3: 3
first study started: 2018

Keep track of what changes. Save the efsubaglutide alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

12 studies that test it; most in 2025 (3)

Studies that test efsubaglutide alfa, by start year
Year	Studies
2018	1
2020	1
2021	2
2023	1
2024	2
2025	3
2026	2

By phase

A phase 1/2 study counts in both.

Phase 1: 4
Phase 2: 6
Phase 3: 3
Phase 4: 1

What it is tested for

Each study’s main condition, where its own words name it.

Diabetes Mellitus, Type 2: 6
Obesity: 3

Who runs them

Industry 0 · Other 12

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. (11) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Often tested with

Tested in the same studies.

Metformin (2) · Digoxin (1)

Studies

Open first, then newest update. How each study uses efsubaglutide alfa is read from its arms, and is right about nine times in ten.

Testing it · 12

Codes

What other systems call efsubaglutide alfa · ClinicalTrials.gg INT015493

UNII (FDA) 7MFJ5FK8CFEFSUBAGLUTIDE ALFAOne source FDA
NCI Thesaurus C211743Efsubaglutide AlfaOne source FDA

System	Code	Name there	Checked by
UNII (FDA)	7MFJ5FK8CF	EFSUBAGLUTIDE ALFA	One source FDA
NCI Thesaurus	C211743	Efsubaglutide Alfa	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.